Method Development and Method Validation for Ramipril and Telmisartan by RP-HPLC in Pharmacentical Dosage form. by Thotakati, Muralikrishna
METHOD DEVELOPMENT AND METHOD VALIDATION FOR RAMIPRIL
AND TELMISARTAN BY RP-HPLC IN PHARMACENTICAL DOSAGE
FORM.
PHARMACEUTICAL ANALYSIS 
26116628
Dept. of pharmaceutical analysis                                                        JKKMMRF college of pharmacy 
Telmisartan
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INTRODUCTION
Analytical  chemistry  has  played  a  major  role  in  the  changes  facing  the
pharmaceutical Industry today.  Traditionally viewed as a service organization, the
analytical department has become a significant parameter in the drug development
process.  Indeed, the demand for analytical data has become a critical path activity
for selection of molecule for full development.  The pharmaceutical analysis plays a
major role in assuring, identity, safety, efficacy, purity and quality of drug product
the need for pharmaceutical analysis is driven largely by regulatory requirements.
(Satinder Ahuja, 2005; Takeru Higuchi, 2002)
The discipline of analytical chemistry consists of, 
 Qualitatitive analysis: - Which reveals the identity of element and compound
in a sample. (Alexeyev, 1994)
 Quantitative  analysis:  -  Indicate  the  amount  of  individual  element  or
compound present in sample.
 Method of Quantitative Analysis (Devaraj Rao, 2004)
Under the Quantitative Analysis, the Procedures of quantitative analytical chemistry
are applied to the analysis of material used in pharmaceuticals.
There are various methods for quantitative analysis of pharmaceuticals.  In
general the components are related characteristically to some physical property and
on the basis of that, the quantity is estimated.  They are classified into the following
types:
 Chemical Methods
 Volumetric or Titrimetric
∗ Acid-base or Neutralization Titrations
∗ Oxidation –Reduction or Redox Titrations
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∗ Precipitation Titration
∗ Complex metric Titrations
∗ Non-aqueous Titrations
∗   Gravimetric
∗  Geometric
 Instrumental or Physio-chemical methods
Instrumental  methods  are  based  on  the  relation  between  the  content  and
corresponding physical or physio-chemical Properties of the system being analyzed. 
 Chromatographic Methods
∗ Thin Layer Chromatography (TLC)
∗  Paper Chromatography 
∗ Column Chromatography
∗  Gas Chromatography
∗  High Performance Liquid Chromatography (HPLC)
 Hyphenated Techniques
 GC-MS (Gas Chromatography – Mass Spectrometry)
 LC-MS (Liquid Chromatography – Infrared Spectroscopy)
 ICP-MS (Inductive Coupled Plasma – Mass Spectrometry)
 Microbiological Methods
 Biological Methods
 Factors effecting the choice of analytical methods (Mendham, 2002)
 The type of analysis required. 
 Problem arising from the nature of the material
 Possible interference from components of the material other than those of  
Interest.       
 The Concentration range which needs to be investigated.
 The accuracy required
 The facilities available
 The time required for complete analysis
 Similar type of analysis performed
CHROMATOGRAHY
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Chromatography  is  family  of  Analytical  chemistry  techniques  for  the
separation of mixtures.  It involves passing the sample, mixture which contains the
analyte,  in  the  “mobile  phase”  often  in  a  steam of  solvent,  through  “stationary
phase”.  The stationary phase retards the passage of the components of the sample.
When components pass through the system at different rates they become separated
in time, like runners in a marathon.  Ideally, each component has characteristic time
of passage through the system.  This is called its “retention time”. (Clark’s 2004). 
 Physical  separation  method  in  which  the  components  of  a  mixture  are
separated by differences in their distribution between two phases, one of which is
stationary (stationary phase) while the other (mobile phase) moves through it in a
definite  direction.   The substances  must  interact  with  the  stationary phase to  be
retained and separated by it.  
A  chromatograph  takes  a  chemical  mixture  carried  by  liquid  gas  and
separates it into its component parts as a result of differential distributions of the
solute  as  they flow around  or  over  a  stationary liquid  or  solid  phase.   Various
techniques for separation of complex mixtures relay on the differential affinities of
substances for a gas or liquid mobile medium and for a stationary absorbing medium
through which they pass; such as paper, gelatin, or magnesium silicate gel. 
Analytical  chromatography  is  used  to  determine  the  identity  and
concentration of the molecules in mixture.  Preparative chromatography is used to
purify large quantities of a molecular species. 
DEFINITIONS FOR CHROMOTOGRAPHY
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          Chromatography is a physical method of separation in which the compound to
be  separated  or  distributed  between  two  phase.   One  of  which  is  stationary
(stationary phase) while the other mobile (Mobile phase) moves in definite direction
(IUPAC, 1993). 
THE DIFFERENT TYPES OF CHROMATOGRAHY
Adsorption chromatography 
Adsorption  chromatography  probably  one  of  the  oldest  types  of  the
chromatography around.   It  utilizes  a  mobile  liquid  or  a  gaseous  phase  that  is
adsorbed on to the surface of a stationary solid phase.  The equilibration between
mobile and stationary phase accounts for the separation of different solutes.
Partition chromatography
This form of chromatography is based on a thin film formed on the surface
of the solid support by a liquid stationary phase.  Solute equilibrates between the
mobile phase and the stationary liquid. 
Ion Exchange chromatography
In this type of chromatography the use of resin ( the stationary solid phase) is
used to a covalently attach anions or a cations on to it.  Solute ions of the opposite
charge in the mobile liquid phase are attracted to the resin by electro static forces. 
Molecular Exclusion Chromatography
Also known as Gel Permeation or Gel Filtration, this type of chromatography
lacks an attractive interaction between the stationary phase and solute.  The liquid or
gaseous phase passes through a porous gel, which separates the molecules according
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to its size.  The pores or normally small and exclude the larger solute molecules, but
allows smaller molecules to enter the gel, causing them to flow through a larger
volume.  This causes the larger molecules to pass through the column at faster than
the smaller once. 
Affinity Chromatography
This is the most selective type of chromatography employed.  It utilizes the
specific interaction between one kind of solute molecule and a second molecule.
That is immobilized on a stationary phase. For example, the immobilized molecule
may be an antibody to some specific protein.  When solute containing a mixture of
proteins  is  passed  by this  molecule,  only the  specific  protein  is  reacted  to  this
antibody, binding it to the stationary phase.
This protein is later extracted by changing the ionic strength or PH.
Working principle
In all chromatography there is an mobile phase and stationary phase.  The
stationary phase is a phase that doesn’t move and the mobile phase is the phase does
moves.   The  mobile  phase  moves  through  the  stationary  phase  picking  up  the
compounds  to  tested.   As  the  mobile  phase  continuous  to  travel  through  the
stationary phase it takes the compounds with it.  At different points in the stationary
phase the different components of the compound are going to be absorbed and are
going  to  stop  moving  within  the  mobile  phase.   This  is  how  the  results  the
chromatography are gotten, from the point at which the different components of the
compound stop moving and separate from the other components.
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In paper and thin-layer chromatography the mobile phase is the solvent.  The
stationary phase in paper chromatography is strip or piece of the paper that is placed
in the solvent.  In thin-layer chromatography the stationary phase is the thin-layer
cell.  Both these kinds of chromatography use capillary action to move the solvent
through the stationary phase. 
Retention Factor (Rf)
The retention factor, Rf , is the quantitative indication of how far a particular
compound  travels  in  a  particular  solvent.   The  Rf value  is  a  good  indicator  of
whether  and  unknown  compound  and  a  known  compound  are  similar,  if  not
identical.  If the Rf Value for the unknown compound is close or the same as the Rf
Value for the known compound then the two compounds are most likely similar or
identical.  The retention factor, Rf, is defined as Rf = Distance the solute (D1) moves
divided by the distance traveled by the solvent front (D2). 
RF = D1/D2
Where,
D1   = distance that spot travelled, measured from centre of the band of spot to the
point  where Food color was applied.
D2 = total distance that solvent travelled. 
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HIGH PERFORMANCE LIQUID CHROMATOGRAHY
HPLC is able to separate macro molecules and ionic species. Labile, natural
products  polymeric  materials  and  a wide  variety of  other  high-molecular  weight
polyfunctional groups.
High performance liquid chromatography is a separation technique utilizing
differences in distribution of compounds to two phases; called stationary phase and
mobile phase.
Basic Principle of HPLC
High performance liquid chromatography is  separation technique utilizing
differences in distribution of compounds to two phase; called stationary phase and
mobile phase.  The stationary phase designates a thin layer created on the surface of
fine particles and the mobile phase designates the liquid flowing over the particles.
Under  a  certain  dynamic  condition  each  component  in  a  sample  has  different
distribution equilibrium depending on the solubility in the phases and or molecular
size.  As a result the components move at different speeds over the stationary phase
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and are there by separated from each other the column is stainless steel (or resin)
tube which is packed with spherical solid particles.  Mobiles phase is constantly fed
in to the column inlet at a constant rate by a liquid pump.  A sample is injected from
sample  injector  located  near  the  column  inlet.   The  injected  sample  enters  the
columns with the mobile phase and the components in the sample migrate through it
passing between stationary and mobile phases.  Compound move in the column only
when it is in the mobile phase.  Compounds that tend to be distributed in the mobile
phase therefore migrate faster through the column while the compounds that tend to
distributed in the stationary phase migrates slower.  In this way each component is
separated on the column and sequentially elutes from the outlets.  Each compound
eluting from the column is detected by a detector connected to the outlet  of the
column.  
TYPES OF HIGH PERFORMANCE LIQUID CHROMATOGRAHY
Based on modes of chromatography
 Normal phase chromatography
 Reverse phase chromatography
Based on Principles of separation
 Adsorption chromatography
 Ion exchange chromatography
 Ion pair chromatography
 Size exclusion chromatography
 Affinity chromatography
 Chiral phase chromatography
Based on elusion technique
 Isocratic separation
 Gradient separation
Based on the scale of operation
 Analytical HPLC
 Preparative HPLC
Isocratic Elution
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In Isocratic elution a sample is injected onto a given column and the mobile
phase is unchanged through the time required for the sample components to elute
from  the  column.   The  isocratic  separation  of  samples  widely  varying  with  k’
(partition ratio) values long elution times.  To adequately handle samples that have
both weakly retained and strongly retained and strongly retained substances,  the
rates of individual band migrations must be changed.
Gradient Elution
Steady changes of the mobile phase composition during the chromatographic
run are called gradient elution.  The main purpose of gradient elution is to move
strongly retained components of  the mixture faster,  but  having the least  retained
component well resolved.
Starting with the low content of  the organic component  in  the eluent  we
allow the least retained components to be separated.  Strongly retained components
will sit on the adsorbent surface on the top of the column, or will move very slowly. 
When we start  to increase an amount of organic component in the eluent
(Acetonitrile)  then  strongly  retained  components  will  move  faster  and  faster,
because of the steady increase  of the competition for the adsorption sites.
Gradient  elution  also  increases  quasi-efficiency  of  the  column.   In  the
isocratic elution, the longer a component is retained the wider its peak.  In gradient
elution especially with the smooth gradient shape without flat regions the tail of the
peak is always under the influence of the stronger mobile phase when compared to
the peak front.  Thus molecules on the tail of the chromatographic zone (peak) will
move faster.  This will tend to compress zone and narrow the resultant peak. 
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The optimum gradient  for  a  particular  separation  is  selected  by trial  and
error.
Normal Phase High Performance Liquid Chromatography (NP-HPLC)
Normal  –  phase  Liquid  –  liquid  chromatography uses  a  polar  stationary
phase and less polar mobile phase.  To select an optimum mobile phase, it is best to
start  with  a  pure  hydrocarbon  mobile  phase  such  as  heptane.   If  the  sample  is
strongly retained the polarity of the mobile phase should be increased, perhaps by
adding small amounts of methanol or dioxane. 
Reverse Phase High Performance Liquid Chromatography (RP-HPLC)
In the normal phase mode, separations of oil-soluble vitamins, essential oils,
nitro  phenols,  or  more  polar  homologous  series  has  been  performed  using
alcohol/heptane  as  the  mobile  phase.  Column  used  in  the  normal  phase
chromatography for chiral separation
Reverse phase chromatography uses hydrophobic bonded packing, usually
with  an  octadecyl  or  octyl  functional  group  and  a  polar  mobile  phase,  often  a
partially or fully aqueous mobile phase.  Polar substances prefer the mobile phase
and  elute first.   As the  hydrophobic character  of  the  solutes  increases,  retention
increases.  Generally, the lower the polarity of the mobile phase, the higher is its
eluting strength.   The  elution order  of  the  classes  of  the  compounds  in  table  is
reversed  (Thus,  the  name  reverse-phase  chromatography).   Hydrocarbons  are
retained more strongly than alcohols.  Also, the elute strength of the various solvents
reverse-phase  chromatography follows  approximately  the  reverse  order  given  in
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table.  Thus water is weakest elute.  Methanol and Acetonitrile are popular solvents
because they have low viscosity and are readily available with excellent purity.
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Table-1
COMPARISION OF NP-HPLC AND RP-HPLC
Proprietors Normal Phase Reverse Phase
Polarity  of  Stationary
Phase
High Low
Polarity of Mobile Phase Low to Medium Low to High
Sample elution order Leader polar first Most polar first
Retention  will  be
increased by 
Increasing  surface  of
stationary phase
Increasing  of  n-alkyl
chain length of stationary
phase
Decreasing  polarity  of
mobile phase
Increasing  polarity  of
sample
Increasing  surface  of
Stationary phase
Increasing  polarity  of
mobile phase
Decreasing  polarity  of
sample molecules
 Ion exchange chromatography
Ion  exchange chromatography uses  a  stationary phase support  which  has
been derivatized to as to permanently bind charged groups to the surface the mobile
phase  is  typically  as  aqueous  buffer.   This  technique  is  used  primarily  for  the
analysis of ions such as strong acids or basis or for separation of large molecules
such as nucleic acids, proteins, or large peptides.
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Ion-pair chromatography
Ion-pair chromatography is a “hybrid” technique in which charges groups are
temporarily bound to the surface of a (Reverse-phase) type of column packing.  This
technique  is  often  used  for  the  analysis  of  small,  weak-acid  or  weak-base
compounds. 
Size-exclusion chromatography
This  separates  molecules  according  to  their  molecular  mass.   Larger
molecules  are eluted first  and the smallest  molecules  elute last.   This method is
generally  used  when  a  mixture  contains  compounds  with  a  molecular  mass
difference of at least 10%.  This mode can be further subdivided into gel permeation
chromatography (with  organic  solvents)  and  gel  filtration  chromatography (with
aqueous solvents).
Affinity Chromatography
Affinity chromatography operates using immobilized biochemical’s that have
a specific  affinity to the compound of interest.   Separation occurs as  the mobile
phase  and  sample  pass  over  the  stationary  phase.   The  sample  compound  or
compounds of interest are retained as the rest of the impurities and mobile phase
through.  The compounds are then eluted by changing the mobile phase conditions
Dept. of pharmaceutical analysis                  13                     JKKMMRF college of 
pharmacy
Chapter 1 Introduction
HPLC INSTURMENTATION
 The  general  instrumentation  for  HPLC  incorporates  the  following
components:
 There is a solvent reservoir for the mobile phase. 
 Sampling valves or loops are used to inject the sample in the flowing mobile
phase just at the head of the separation column.  Samples should be dissolved
in a portion of the mobile phase to eliminate unnecessary peak.
 Ahead of the separation column there may be a guard column or an in-line
filter to prevent contamination of the main column by small particulate.
 To measure column inlet pressure a pressure gauge is inserted in front of the
separation column.
 The  separation  column  contains  the  packing  needed  to  accomplish  the
desired  HPLC  Separation.   These  may  be  silica’s  for  adsorption
chromatography, bonded phases for liquid-liquid chromatography, exchange
functional  groups  bonded  to  stationary  support  for  exchange
chromatography, gels of specific porosity for exclusion chromatography, or
some unique packing for particular separation method
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Figure 1: A flow Scheme for HPLC
Mobile-phase delivery system
  The mobile phase must be delivered to the column over a wide range of flow
rates and pressure.  A de-gasser is needed to remove dissolved air and other gases
from the solvent.  Another desirable feature in the solvent-delivery system is the
capability for generating a solvent gradient. 
Pump
A pump should able to be operate to at least 1500 psi, a pressure suited to
less expensive chromatographs.   However,  6000 psi  is  a more desirable pressure
limit.  For many analytical columns only moderate flow rates of 0.5 – 2.0 ml / min
need to be generated.
Separation Columns
Column is the important part of a HPLC instrument columns are constructed
of heavy-wall, glass-lined metal tubing or stainless steel tubing to with stand high
pressure (up to 7000 psi) and the chemical action of the mobile phase.  Most column
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lengths range from 10 – 30 cms; short,  fast  columns are 3 to 8 cms long.   For
exclusion chromatography, columns are 50 to 100 cms long. 
Standard Columns
Many HPLC separations are done on columns with an internal diameter of 4
to 5 mm.  Such columns provide a good compromise between efficiency sample
capacity, and the amount of packing and solvent required.  Column packing feature
particles that is uniformly sized and mechanically stable.  Particle diameters lie in
the  range  3  –  5  ml,  occasionally  up  to  10  ml  or  higher  for  preparative
chromatography.  The columns are classified into various categories depending on
their carbon loading. 
Detectors
The sensitivity of universal detector for HPLC as not been devised yet.  Thus
it is necessary to select a detector on the basis of the problem. 
UV Visible Photometers and Spectrometers
Optical  detectors  based  on  UV-Visible  absorption  are  the  workhorses  of
HPLC, constituting over 70% of all detections system of all in us.  Basically three
types of absorbance detectors are available: a fixed wavelength detector, a variable
detector, and a scanning wavelength.
Fixed wave length detectors
A fixed wavelength detector uses a light source that emits maximum light
intensity  at  one  or  several  discrete  wavelengths  that  are  isolated  by appropriate
filters. 
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Variable Wavelength detector
A variable wave length detector is  a relatively wide-band pass it  offers a
wide selection of UV and Visible wavelength, but at increased cost.
Photo Diode Array (PDA) Detector
To obtain a real time spectrum for each solute at it elutes, solid-state diode
arrays are required.  The diode arrays work in parallel simultaneously monitoring all
wavelengths.
Digital electronic integrators
Were, widely used today in HPLC for measuring Peak areas.  These devices
automatically sense peaks and print out the areas in numerical forms.  Computing
integrators are even more sophisticated and offer a number of features in addition to
basic digital integration because these devices have both memory and computing
capabilities to upgrade integrating parameters to maintain accuracy as the separation
progress  and  eluting peaks  become broader.   Many of  these devices  print  out  a
complete report including names of the compounds, retention times, peak areas and
area correction factors.  With the help of peak area and height values, the peak width
can be calculated (considering the peak as a triangle) and it can also be used for the
calculation of number of theoretical plates. 
BUFFERS IN REVERSED-PHASE LIQUID CHROMOTOGRAPHY
Selection  of  a  buffered  aqueous  mobile  phase  for  reversed-phase  liquid
chromatography (RPC) may seen intimidating,  but  with  an understanding of  the
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fundamental  effect  of  pH  on  retention  of  ionic  analytes  and  checking  some C.
Properties of the buffer options, a logical and reasonable choice can be derived.
This selection may need to be revised by consideration of certain factors,
such  as  solubility  or  limitations  of  compatibility  with  the  means  of  detection.
Practical aspects of buffer preparation should also be observed for reproducible and
trouble-free operation. 
The pH of the mobile phase will dramatically effect the retention of ionic
analytes within 1.5 pH units of their pKa.  Thus, it can be understood why control of
mobile  phase  pH  has  great  utility  in  method  development  and  is  critical  for
reproducible separations of ionic analytes.  Obviously,  if the analyte is not ionic,
mobile phase pH won’t directly effect its retention.
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Table-2
Buffer
pKa
 
(25°C) Maximum buffer
range UV Cutoff (nm)
TFA 0.3 _ 210 (0.1%)
Phosphate,H2PO4 pK1 2.1 1.1-3.1 <200
Phosphate,pK2HPO42- 7.2 6.2-8.2 <200
Phosphate, pK3 PO4 3- 12.3 11.3-13.3 <200
Citrate,pKC3H5O
(CO2H)2 (CO2-)1 3.1 2.1-4.1 230
Citrate, pK2 C3H5O
(CO2H)1 (CO2-)2 4.7 3.7-5.7 230
Citrate, pK3   C3H5O
(CO2-)3 6.4 4.4-6.4 230
Carbonate,pK1HCO32- 6.1 5.1-7.1 <200
Carbonate, pK2 CO32- 10.3 9.3-11.3 >200
Formate 3.8 2.8-4.8 210 (10 NM)
Acetate 4.8 3.8-5.8 210 (10 NM)
Ammonia 9.3 8.3-10.3 200 (10 NM)
Borate 9.2 8.2-10.2 N/A
TEA 10.8 9.8-11.8 <200
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SELECTIVITY OF HPLC – METHOD DEVELOPMENT
Most  of  the drugs can be analyzed  by HPLC method because  of  several
advantages  like  rapidity,  specificity,  accuracy,  precision,  case  of  automation  and
eliminates tedious extraction and isolation procedures.  Some of the advantages are:
∗ Speed (analysis can be accomplished in 20 or Less)
∗ Greater sensitivity (Various detectors can be employed))
∗ Improved Resolution (Wide variety of stationary phases)
∗ Reliable columns (Wide variety of stationary phases)
∗ Ideal for substances of low volatility
∗ Easy sample recovery, handling and maintenance 
∗ Easy programming of the numerous functions in each module
∗ Time  programmable  operation  sequence,  such  as  initiating  operation  of
detector lamp and pump to obtain a stable baseline and equilibrated column before
the work day begins.
∗ Excellent reproducibility of retention times.
∗ An  injection  volume  variable  from  0.1  to  100  micro  liters  without  any
hardware modification.
∗ The flexibility of data analysis.
∗ Suitable to avoid any interference from impurity.
Suitable, for preparative liquid chromatography on a much larger scale.
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METHOD DEVELOPMENT BY RP-HPLC
HPLC method development is not very difficult when a literature reference
for the same or similar compounds to be analyzed can be found.
The first consideration when developing an HPLC method is to determine
the solubility of the sample components.  Knowing the nature of the analytes will
allow  the  most  appropriate  mode  of  the  HPLC  to  be  selected.   Summarizes
appropriate  separation  modes  and  mobile  phases  to  consider  for  method
development.  (Complex sample may require an initial clean – up step to remove
possible interferences) there is a temptation to quickly take an appropriate column,
prepare a sample and suitable mobile phase, and run it on the HPLC system.  This
may  with  some  trial  and  error,  but  the  key  to  efficient  method  development
planning.
THE BEST DETECTORS
The next consideration should be choice of detector.  There is a little use in
running a separation if  the detector one uses cannot “see” all the components of
interest, or conversely, if it “see” too much.  UV – Vis detectors are the most popular
as they can detect a broad range of compounds and have a fair degree of selectivity
for some analytes.  Unfortunately UV – Vis detectors are not universal detectors so it
is worthwhile to look at the chemical structure of the analyte to see if it has suitable
chromophores, such as aromatic rings, for UV – Vis detection.
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Table.3 summarizes some of the available options.
THE BEST COLUMN LENGTH
Many chromatograms make the mistake of simply using what is available.
Often this a 250 x 4.6 mm c18 column.  These columns are able to resolve a wide
variety of compounds (due to their selectivity and plate counts) and more common
to most laboratories.  While many reverse phase separations can be carried out on
such a column, its high resolving capabilities are often unnecessary, as illustrated
fig. 2.  Method development can be streamlined by starting with shorter column;
150,  100,  or  even  50  mm long.   This  simply because  they have  proportionally
shorter run times.  
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THE BEST STATIONARY PHASE
Selecting  an  appropriate  stationary  phase  can  also  help  to  improve  the
efficiency of method development.  For example, a C8 phase (reverse phase) can
provide a further time saving over a C18, as it does not retain analytes as strongly as
the C18 phase.  For normal phase applications, cyano (nitrile) phase are the most
versatile.
THE BEST MOBILE PHASE
Since the mobile phase governs solute-stationary phase interactions, it choice
is critical.  Practical considerations dictate that it should not degrade the equipment
or the column packing.  For this reason, strong acids, bases and halide solutions
should be avoided.  Chemical purity of solvents are pumped through the column,
trace impurities can easily concentrate in the column and eventually be determined
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to the results.  AR and HPLC grade solvents are recommended.  Volatility should be
considered if sample recovery is required.
Viscosity  should  be  less  than  0.5  centipoises,  otherwise  higher  pump
pressure are required and mass transfer between solvent and stationary phase will be
reduced LC/MS – only volatile buffers.
THE BEST INTERNAL DIAMETER 
By selecting a shorter column with an appropriate phase, run times can be
minimized so that an elution order and an optimum mobile phase can be quickly
determined.  It can also be advantageous to consider the column internal diameter.
Many laboratories use 4.6 mm ID Columns as a standard, but it is worth considering
the use of 4 mm ID Columns as an alternative.  These require only 75% of solvent
flow that a 4.6 mm column uses.  This translates to a 25% solvent saving over the
life of the column and can be even more significant if a routine method is developed
for such a column. 
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POLARITY  OF  COMMON  ORGANIC  FUNCTIONAL  GROUPS  AND
SOLVENT
Functional Groups    Non-polar Solvent
Aliphatic hydrocarbons Hexane
Olefins Carbon
tetrachloride
Aromatic hydrocarbons Ether
Halides Benzene
Sulphides Methylchloride
Ethers THF
Nitro components Isopropanol
Esters, aldehydes, ketones Chloroform
Alcohols, amines Ethyl acetate
Sulphones Acetonitrile
Sulphoxides       Polar Methanol
Amides Water
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ANALYTICAL METHOD VALIDATION
Method  validation  can  be  defined  as  (ICH)  “Establishing  documented
evidence,  which provides a high degree of  assurance that a specific activity will
consistently  produce  a  desired  result  or  product  meeting  its  predetermined
specifications and quality characteristics”.
           Method validation is an integral part of the method development; it  is the
process by which a method is tested by the developer or user for reliability, accuracy
and preciseness of its intended purpose and demonstrating that analytical procedures
are suitable for their intended use that they support the identity, quality, purity, and
potency of the drug substances and drug products Data thus generated become part
of  the methods validation package submitted to  Center for  Drug Evaluation and
Research  (CDER). Simply,  method  validation  is  the  process  of  proving  that  an
analytical method is acceptable for its intended purpose.   
Methods  should  be  reproducible  when  used  by  other  analysts,  on  other
equivalent equipment, on other days or locations, and throughout the life of the drug
product.  Data  that  are  generated  for  acceptance,  release,  stability,  or
pharmacokinetic will only be trustworthy if the methods used to generate the data
are reliable. The process of validation and method design also should be clearly in
the development cycle before important data are generated. Validation should be on
going  in  the  form  of  re-validation  with  method  changes.  (United  states  of
Pharmacopeia XX11)
Though many types of HPLC techniques are available, the most commonly
used method, the reversed-phase HPLC with UV detection, is selected to illustrate
the parameters for validation. The criteria for the validation of this technique can be
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extrapolated  to  other  detection  methods  and  chromatographic  techniques.  For
acceptance, release or stability testing, accuracy should be optimized since the need
to show deviation from the actual or true value is of the greatest concern.           
All the variables of the method should be considered, including sampling
procedure, sample preparation, chromatographic separation, and detection and data
evaluation.  For chromatographic  methods used in  analytical  applications  there  is
more  consistency  in  validation  practice  with  key  analytical  parameters  includes
namely
 System suitability  
 Specificity  
 Accuracy  
 Precision  
 Linearity  
 Limit of Detection  
 Limit of Quantitation  
 Ruggedness 
 Robustness
 System Suitability
According  to  the  USP,  system  suitability  tests  are  an  integral  part  of
chromatographic  methods.  These  tests  are  used  to  verify that  the  resolution  and
reproducibility of the system are adequate for the analysis to be performed. System
suitability tests are based on the concept that the equipment, electronics, analytical
operations,  and samples  constitute  an integral  system that  can be evaluated as  a
whole.   The purpose of the system suitability test is  to ensure that  the complete
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testing system (including instrument, reagents, columns, analysts) is suitable for the
intended application.
Similar  to  the  analytical  method  development,  the  system suitability  test
Strategy should be revised as the analysts develop more experience with the assay.
In  general,  consistency of  system performance.  (Eg:  Replicate  injections  of  the
standard) and chromatographic suitability. (Eg: Tailing factor, column efficiency and
resolution of the critical pair) are the main components of system suitability.
During the early stage of the method development process some of the more
sophisticated  system  suitability  tests  may  not  be  practical  due  to  the  lack  of
experience with the method. In this stage, usually a more "generic" approach is used.
For example, evaluation of the tailing factor to check chromatographic suitability,
and replicate injections of the system suitability solution to check injection precision
may  be  sufficient  for  an  HPLC  impurities  assay.  As  the  method  matures  more
experience is acquired for this method, a more sophisticated system suitability test
may be necessary.
System suitability is the checking of a system to ensure system performance
before or during the analysis of unknowns. Parameters such as plate count, tailing
factors;  resolution  and  reproducibility  (%RSD  retention  time  and  area  for  six
repetitions)  are  determined  and  compared  against  the  specifications  set  for  the
method. These parameters are measured during the analysis of system suitability
"sample" that is a mixture of main components and expected by-products.             
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Table 4: System suitability parameters and recommendations
Parameter Recommendation
Capacity Factor (k’) The peak should be well-resolved from other peaks and the
void volume, generally k’ 1 to 20
Repeatability RSD < 1% for N > 5 is desirable.
Relative retention Not essential as long as the resolution is stated.
Resolution (Rs)
Rs of > 2 between the peak of interest and the closest eluting
potential  interfering  (impurity,  excipient,  degradation
product, internal standard, etc.
Tailing Factor (T) T of >0.5 and < 2
Theoretical Plates (N) N > 3000
 Specificity/Selectivity 
The  terms  selectivity  and  specificity  are  often  used  interchangeably.
According to ICH, the term specific generally refers to a method that produces a
response for a single analyte only while the term selectivity refers to a method that
provides  responses  for  a  number  of  chemical  entities  that  may  or  may  not  be
distinguished  from  each  other.  If  the  response  is  distinguished  from  all  other
responses, the method is said to be selective. Since there are very few methods that
respond to only one analyte, the term selectivity is usually more appropriate.  
Specificity is the ability of a method to discriminate between the analyte(s)
of interest and other components that are present in the sample. Studies are designed
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to  evaluate  the  degree  of  interference,  if  any,  which  can  be  attributed  to  other
analytes,  impurities,  degradation  products,  reagent  "blanks"  and  excipients.  This
provides the analyst with a degree of certainty that the response observed is due to
the single analyte of interest. The degree of specificity testing varies depending on
the  method  type  and  the  stage  of  validation.  Specificity  should  be  evaluated
continually through the drug development process.  Specificity is  sometimes used
interchangeably with the term "selectivity". The argument over which term is more
correct is one of semantics. Although there is some dissention, the term "specificity"
has  been  adopted  by the  regulatory guidance  documents  and  should  be  used  to
prevent further confusion.
 Non-Interference of Placebo
This portion of specificity evaluation applies to the finished drug product
only.  Excipients  present  in  the  formulation  should  be  evaluated  and  must  not
interfere with the detection of the analyte.  Individual  solutions of  each excipient
prepared at several times the normal concentration of the component in the drug
product ensure that any detector response from the excipient will be readily visible.
Injecting individual solutions of each excipient into the HPLC system in comparison
with a standard solution of the analyte is one means of performing this experiment.
The  absence  of  a  peak  eluting  at  the  retention  time  of  the  active  ingredient  is
sufficient to demonstrate specificity for excipients. 
Challenge Study
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Injecting  solutions  of  known  process  impurities,  degradation  products,
intermediates,  homologues,  dimers  etc.  further  challenges  the  specificity  of  a
method. Identification of these compounds may require an extensive search in order
to identify all possible species that may be present in the sample. For new chemical
entities  (NCE),  this  information may not  be readily available.  Probable suspects
should be identified  by careful  review of  the  synthetic  route  and  manufacturing
process to identify any likely species that may be present in the sample. 
 Degradation Studies
Degradation  studies  involve  exposing the sample  to  a  variety of  stressed
conditions to further evaluate the specificity of degradation products. In this study,
the drug substance, drug product, and the combined recipients (or placebos) are each
exposed to the stressed conditions. These may include, but are not limited to, heat,
light, acidic media, alkaline media, and oxidative environments.  Other conditions
may be used  depending on the nature  and  chemistry of  the  test  subject.  Forced
degradation is usually evaluated with not more than 20% degradation of the drug
substance, although more may be acceptable depending on the particular properties
of the drug. A reasonable effort  should be made to degrade samples in order  to
identify possible degradation products. If the planned experiments do not show any
appreciable degradation, the strength and/or exposure time of the stress condition
may be increased, but degradation is not required for every condition studied. There
is a point beyond which the stress condition becomes extreme and unrealistic. Sound
scientific judgment should be used to determine the extent and degree of degradation
studies.
 Accuracy
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Accuracy is the measure of how close the experimental value is to the true
value.  Accuracy should be established across the specified range of the analytical
procedure.
Assay
 (Drug Substance)
Several methods of determining accuracy are available:
a) Application of an analytical procedure to an analyte of known purity (e.g.
reference material);
b) Comparison of the results of the proposed analytical procedure with those of
a  second  well-characterized  procedure,  the  accuracy  of  which  is  stated  and/or
defined.
c) Accuracy may be inferred once precision, linearity and specificity have been
established.
 Drug Product
Several methods for determining accuracy are available:
a. Application of  the analytical  procedure to  synthetic  mixtures  of  the drug
product components to which known quantities of the drug substance to be analyzed
have been added.
b. In cases where it is impossible to  obtain  samples  of  all  drug  product
components, it may be acceptable either to add known quantities of the analyte to
the  drug   product  or   to   compare   the   results   obtained  from a  second,  well
Characterized procedure, the accuracy of which is stated and/or defined.
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c. Accuracy may be inferred once precision, linearity and specificity have been
established.
 Impurities (Quantitation)
Accuracy  should  be  assessed  on  samples  (drug  substance/drug  product)
spiked with known amounts of impurities. In cases where it is impossible to obtain
samples  of  certain  impurities  and/or  degradation  products,  it  is  considered
acceptable to compare results obtained by an independent procedure. The response
factor of the drug substance can be used. It should be clear how the individual or
total impurities are to be determined e.g., weight/weight or area percent, in all cases
with respect to the major analyte.
Recommendations
Accuracy should be assessed using a minimum of 9 determinations over a
minimum  of  3  concentration  levels  covering  the  specified  range  (e.g.  3
concentrations / 3 replicates each of the total analytical procedure). Accuracy should
be reported as percent recovery by the assay of known added amount of analyte in
the  sample  or  as  the  difference  between  the  mean  and  the  accepted  true  value
together with the confidence intervals.
 Precision
 Precision is the measure of how close the data values are to each other for a
number of measurements under the same analytical conditions.  ICH has defined
precision  to  contain  three  components:  repeatability,  intermediate  precision  and
reproducibility. Ruggedness as defined in 1990 incorporates the concepts described
under the terms "intermediate precision", "reproducibility" and "robustness" of this
guide.( USP XXII )
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 Repeatability
Injection Repeatability
Sensitivity is the ability to detect small changes in the concentration of the
analyte  in  the  sample.  Sensitivity  can  be  partially  controlled  by  monitoring  the
specification for injection reproducibility (system suitability testing).
The  sensitivity  or  precision  as  measured  by  multiple  injections  of  a
homogeneous sample (prepared solution) indicates the performance of the HPLC
instrument under the chromatographic conditions and day tested. 
The information is provided as part of the validation data and as a system
suitability test.  The specification, as  the coefficient  of  variation in  % or  relative
standard deviation (RSD), set here will determine the variation limit of the analysis.
The tighter the value, the more precise or sensitive to variation one can expect the
results. This assumes that the chromatograph does not malfunction after the system
suitability  testing has  been  performed.  Keep  in  mind,  however,  that  it  does  not
consider variations due to the drug product manufacturing and laboratory sample
preparation procedures. The set of four duplicate samples were injected sequentially.
Variations in peak area and drift of retention times are noted. 
Precision refers to the reproducibility of measurement within a set, that is, to
the scatter of dispersion of a set about its central value. The term ‘set’ is defined as
referring to a number (N) of independent replicate measurements of some property.
One of the most common statistical terms employed is the standard deviation of a
population  of  observation.  Standard  deviation  is  the  square  root  of  the  sum  of
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squares of deviations of individual results for the mean, divided by one less than the
number of results in the set. The standard deviation S, is given by
                                    
Standard deviation has the same units as the property being measured.
 The square of standard deviation is called variance (S2). Relative standard
deviation is the standard deviation expressed as a fraction of the mean, i.e., S/x. It is
sometimes multiplied by 100 and expressed as a percent relative standard deviation.
It becomes a more reliable expression of precision.   
% Relative standard deviation = S x 100 / x
Recommendations
As part of methods validation, a minimum of 10 injections with an RSD of
2% is recommended. With the methods for release and stability studies, an RSD of
2% for precision of the system suitability tests for at least five injections (n=5) for
the active drug either in drug substance or drug product is desirable. For low-level
impurities, higher variations may be acceptable.
Analysis Repeatability
Determination, expressed as the RSD, consists of multiple measurements of
a sample by the same analyst under the same analytical conditions. 
For practical purpose, it is often combined with accuracy and carried out as a single
study.
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 Intermediate Precision
Intermediate  precision  was  previously known as  part  of  ruggedness.  The
attribute evaluates the reliability of the method in a different environment other than
that  used during development of  the method. The objective is  to ensure that the
method will provide the same results when similar samples are analyzed once the
method development phase is over. Depending on time and resources, the method
can be tested on multiple days, analysts, instruments, etc.
Intermediate  precision  in  the  test  method  can  be  partly  assured  by good
system suitability  specifications.  Thus,  it  is  important  to  set  tight,  but  realistic,
system suitability specifications.
Linearity
The linearity of a method is its ability to obtain test results that are directly
proportional to the analyte concentration over a given range. For HPLC methods, the
relationship  between  analyte  concentration  and  detector  response  (peak  area  or
height) is used to make this determination.
 Concentration Ranges
The  concentration  range  used  for  linearity  should  be  large  enough  to
encompass the desired range of the method. A minimum of five concentration ranges
should  be  investigated  and  a  plot  of  the  detector  response  vs.  the  sample
concentration  should  be  generated.  It  is  important  that  the  concentration  ranges
selected for the linearity study are relatively equally spaced throughout the range of
the method (e.g., 50%, 75%, 100%, 125% and 150%), and not clustered, as this will
provide a skewed estimation of linearity. 
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Acceptance Criteria
Acceptance criteria should be evaluated to ensure that they are meaningful
when  compared  with  the  performance  of  the  method.  Table  6  gives  a  list  of
suggested acceptance criteria for use in evaluating method linearity. The ranges in
Table 6 are suggestions only and should be adjusted to ensure that all specification
limits  are  within  the  validated  linear  range  for  any  given  method. Under  most
circumstances,  regression  coefficient  (r)  is  0.999.  Intercept  and  slope  should  be
indicated.
Statistical Analysis
Linearity data should be evaluated using appropriate statistical methods. A
simple regression line of the detector response  vs  the analyte concentration is the
most common means of evaluation. Regulatory agencies require the submission of
the correlation coefficient, y-intercept, slope of the regression line, and the residual
sum of squares for linearity evaluation. A graphical representation of the linearity
data should also be generated.  Additional  analysis  of  the deviation of  the actual
values  from the regression line is  suggested,  especially when the method uses  a
single-point calibration standard. The percent y-intercept is calculated by dividing
the y-intercept by the detector response at the nominal concentration expressed as a
percentage.  For  single-point  calibration,  this  value  should  be  less  than  1-2% to
ensure accurate results.
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Table 5
Limit of Detection
These limits are normally applied to related substances in the drug substance
or drug product.  Specifications on these limits  are submitted with the regulatory
impurities method relating to release and stability of both drug substance and drug
product.
Limit of detection is the lowest concentration of analyte in a sample that can
be  detected,  but  not  necessarily  quantitated,  under  the  stated  experimental
conditions. With UV detectors, it is difficult to assure the detection precision of low-
level compounds due to potential gradual loss of sensitivity of detector lamps with
age, or noise level variation by detector manufacturer. At low levels, assurance is
needed that the detection and quantitation limits are achievable with the test method
each  time.  With  no  reference  standard  for  a  given  impurity  or  means  to  assure
detectability,  extraneous  peak(s)  could  "disappear/appear."  A  crude  method  to
evaluate the feasibility of the extraneous peak detection is to use the percentage
claimed for detection limit from the area counts of the analyte. Several approaches
for determining the detection limit are possible, depending on whether the procedure
is a non-instrumental or instrumental. 
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 Based on Visual Evaluation
Visual evaluation may be used for non-instrumental methods but may also be
used with instrumental methods. The detection limit is determined by the analysis of
samples with known concentrations of analyte and by establishing the minimum
level at which the analyte can be reliably detected.
Based on Signal-to-Noise
This approach can only be applied to analytical  procedures which exhibit
baseline noise. Determination of the signal-to-noise ratio is performed by comparing
measured signals from samples with known low concentrations of analyte with those
of blank samples and establishing the minimum concentration at which the analyte
can  be  reliably  detected.  A signal-to-noise  ratio  between  3  or  2:1  is  generally
considered acceptable for estimating the detection limit.
 Based on the Standard Deviation of the Response and the Slope
The detection limit (DL) may be expressed as:
Where,σ = the standard deviation of the response
S = the slope of the calibration curve
The slope S may be estimated from the calibration curve of the analyte. The
estimate of s may be carried out in a variety of ways, for example
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Based on the Standard Deviation of the Blank
Analyzing  an  appropriate  number  of  blank  samples  and  calculating  the
standard deviation of  these responses  perform measurement  of  the magnitude of
analytical background response.
 Based on the Calibration Curve
A specific calibration curve should be studied using samples containing an
analyte in the range of DL. The residual standard deviation of a regression line or
the standard deviation of y-intercepts of regression lines may be used as the standard
deviation.
 Recommendations
The detection limit and the method used for determining the detection limit
should be presented. If  DL is determined based on visual evaluation or based on
signal to noise ratio, the presentation of the relevant chromatograms is considered
acceptable for justification.
In  cases  where  an  estimated  value  for  the  detection  limit  is  obtained  by
calculation  or  extrapolation,  this  estimate  may subsequently  be  validated  by the
independent analysis of a suitable number of samples known to be near or prepared
at the detection limit.
Limit of Quantification
Limit of quantitation is the lowest concentration of analyte in a sample that
can  be  determined  with  acceptable  precision  and  accuracy  under  the  stated
experimental conditions. Several approaches for determining the quantitation limit
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are  possible,  depending  on  whether  the  procedure  is  a  non-instrumental  or
instrumental. 
Based on Visual Evaluation
Visual evaluation may be used for non-instrumental methods but may also be
used with instrumental methods. The quantitation limit is generally determined by
the analysis of samples with known concentrations of analyte and by establishing the
minimum level at which the analyte can be quantified with acceptable accuracy and
precision.
 Based on Signal-to-Noise Approach
This  approach  can  only  be  applied  to  analytical  procedures  that  exhibit
baseline noise. Determination of the signal-to-noise ratio is performed by comparing
measured signals from samples with known low concentrations of analyte with those
of  blank  samples  and  by  establishing  the  minimum concentration  at  which  the
analyte can be reliably quantified. A typical signal-to-noise ratio is 10:1.
Based on the Standard Deviation of the Response and the Slope
The quantitation limit (QL) may be expressed as:
                              
Where,
σ = the standard deviation of the response
S = the slope of the calibration curve
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The slope S may be estimated from the calibration curve of the analyte. The
estimate of s may be carried out in a variety of ways.
 Based on Standard Deviation of the Blank
Measurement  of  the  magnitude  of  analytical  background  response  is
performed by analyzing an appropriate number of blank samples and calculating the
standard deviation of these responses.
 Based on the Calibration Curve
A specific calibration curve should be studied using samples, containing an
analyte in the range of QL. The residual standard deviation of a regression line or
the standard deviation of y-intercepts of regression lines may be used as the standard
deviation. 
 Recommendations
The quantitation limit and the method used for determining the quantitation
limit should be presented. The limit should be subsequently validated by the analysis
of a suitable number of samples known to be near or prepared at the quantitation
limit.  Otherwise the information that is expressed as % area or height of the drug
substance peak from the same HPLC chromatogram will be biased. It should also be
noted that  the extraneous peak using area count  does  not  consider  the detection
response  that  depends  on  the  UV  extinction  coefficient  or  absorptivity  of  the
compound.
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Ruggedness
The ruggedness of an analytical method is the degree of reproducibility of
test  results  obtained  by  the  analysis  of  the  same  samples  under  a  variety  of
conditions,  such as  different  laboratories,  analysts,  instruments,  reagents,  elapsed
assay times,  assay temperatures,  or days.  It  is  normally expressed as the lack of
influence on test results of operational and environmental variables of the analytical
method. Method Ruggedness is defined as the reproducibility of results when the
method is performed under actual use conditions. Method ruggedness may not be
known when a method is first developed, but insight is obtained during subsequent
use of that method.  
Recommendations
The ruggedness of an analytical method is determined by analysis of aliquots
from  homogeneous  lots  in  different  laboratories,  by  different  analysts,  using
operational  and environmental  conditions  that  may differ  but  are still  within the
specified parameters of the assay. The degree of reproducibility of test results is then
determined  as  a  function  of  the  assay  variables.  This  reproducibility  may  be
compared to the precision of the assay under normal conditions to obtain a measure
of the ruggedness of the method.
Robustness
ICH defines robustness as a measure of the method's capability to remain
unaffected by small, but deliberate variations in method parameters. Robustness can
be  partly  assured  by  good  system  suitability  specifications.  The  evaluation  of
robustness should be considered during the development phase and depends on the
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type of procedure under study.  It  should show the reliability of an analysis with
respect  to  deliberate  variations  in  method  parameters.  If  measurements  are
susceptible to variations in analytical conditions, the analytical conditions should be
suitably controlled or a precautionary statement should be included in the procedure.
One consequence of the evaluation of robustness should be that a series of system
suitability parameters (e.g., resolution test) is established to ensure that the validity
of the analytical procedure is maintained whenever used.
Examples of typical variations are:
 Stability of analytical solutions
 Extraction time
In the case of liquid chromatography, examples of typical variations are
 Influence of variations of pH in a mobile phase
 Influence of variations in mobile phase composition
 Different columns (different lots and/or suppliers)
 Temperature
 Flow rate.
In the case of gas chromatography, examples of typical variations are
 Different columns (different lots and/or suppliers)
 Temperature
 Flow rate.
Recommendations
Data obtained from studies for robustness, though not usually submitted, are
recommended to be included as part of method validation. 
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General Recommendation:
System  suitability  testing  is  essential  for  the  assurance  of  the  quality
performance of the chromatographic system. The amount of testing required will
depend on the purpose of the test  method. For dissolution or release profile test
methods  using  an  external  standard  method,  k',  T  and  RSD  are  minimum
recommended  system  suitability  tests.  For  acceptance,  release,  stability,  or
impurities/degradation methods using external  or internal standards,  k',  T, RS and
RSD  are  recommended  as  minimum  system  suitability  testing  parameters.  In
practice,  each  method  submitted  for  validation  should  include  an  appropriate
number  of  system  suitability  tests  defining  the  necessary  characteristics  of  that
system. Additional tests may be selected at  the discretion of the applicant or the
reviewer.
HPLC methods for drug substance and drug product, methods should not be
validated as a one-time situation, but methods should be validated and designed by
the developer or user to ensure ruggedness or robustness throughout the life of the
method.  The  variations  due  to  the  drug  product  manufacturing  process,  the
laboratory sample preparation procedure and the instrument performance contribute
to the accuracy of the data obtained from the analysis. With proper validation and
tight chromatographic performance (system suitability) criteria, an improvement in
the reliability of the data can be obtained. Variations except from the drug product-
manufacturing process will be minimized only with good reliable validated methods
can data that are generated for release, stability, and pharmacokinetic is trust-worthy.
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LITERATURE REVIEW
RP-HPLC estimation of ramipril and telmisartan in tablets,  Kurade .V.P
et  at., (2009),
A  rapid  high  performance  liquid  chromatographic  method  has  been
developed  and  validated  for  the  estimation  of  ramipril  and  telmisartan
simultaneously in combined dosage form. A Genesis C18 column having dimensions
of 4.6×250 mm and particle  size of  5 µm in isocratic  mode, with mobile  phase
containing a mixture of 0.01 M potassium dihydrogen phosphate buffer (adjusted to
pH  3.4  using  orthophosphoric  acid):  methanol:acetonitrile  (15:15:70  v/v/v)  was
used. The mobile phase was pumped at a flow rate of 1.0 ml/min and the eluents
were monitored at 210 nm. The selected chromatographic conditions were found to
effectively separate ramipril (R
 t : 3.68 min) and telmisartan (R t : 4.98 min) having a
resolution  of  3.84.  The  method  was  validated  in  terms  of  linearity,  accuracy,
precision,  specificity,  limit  of  detection  and  limit  of  quantitation.  Linearity  for
ramipril and telmisartan were found in the range of 3.5-6.5 µg/ml and 28.0-52.0
µg/ml, respectively. The percentage recoveries for ramipril and telmisartan ranged
from 99.09-101.64% and 99.45-100.99%, respectively. The limit of detection and
the limit  of  quantitation for  ramipril  was found to  be 0.5  µg/ml  and 1.5  µg/ml
respectively  and  for  telmisartan  was  found  to  be  1.5  µg/ml  and  3.0  µg/ml,
respectively. The method was found to be robust and can be successfully used to
determine the drug content of marketed formulations.
Development  and  Validation  of  RP-HPLC  Method  for  Simultaneous
Estimation  of  Ramipril,  Telmisartan  and  Hydrochlorothiazide  in
Pharmaceutical Dosage Forms,  Kalyan Kumar .B et al ., (2011)
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A new simple, accurate, rapid and precise isocratic High performance liquid
chromatographic (HPLC) method was developed and validated for the determination
of Hydrochlorothiazide (HCTZ), Ramipril (RAM) and Telmisartan (TEL) in tablet
formulation. The Method employs Waters HPLC system on XTerra RP8 Column
(4.6 x 150 mm and 3.5 Âµm) and flow rate of 0.8 ml/min with a load of 20Âµl.
Acetonitrile and Phosphate buffer was used as mobile phase in the composition of
45:55.  The  Detection  was  carried  out  at  215  nm.  Linearity  ranges  for
Hydrochlorothiazide, Ramipril and Telmisartan were 12.5-22.5 Âµg/ml, 5-9Âµg/ml
and  40-72Âµg/ml respectively.  Retention Time of  Hydrochlorothiazide,  Ramipril
and Telmisartan were found to be 2.83 min, 3.65 min and 5.03 min respectively.
Percent Recovery study values of HCTZ, RMP and TEL were found to be within 98-
102 %.This newly developed method was successfully utilized for the Quantitative
estimation  of  Hydrochlorothiazide,  Ramipril  and  Telmisartan  in  pharmaceutical
dosage  forms.  This  method  was  validated  for  accuracy,  precision,  linearity  and
Robustness as per ICH guidelines.
RP-HPLC  Method  for  Simultaneous  Estimation  of  Telmisartan  and
Ramipril in Tablet Dosage Form,  Harikridhnan .N  et al .,(2011)   
A simple,  selective,  rapid,  precise  and  economical  reverse  phase  HPLC
method  has  been  developed  for  the  simultaneous  estimation  of  telmisartan  and
Rampiril in tablet formulation. Chromatography was performed on a ODS Hypersil
C18 (25cm x 4.6 mm i.d., 5µ) column from thermo in isocratic mode with a mobile
phase consisting of acetonitrile: 10mM KH2PO4 PH 3.0 (40:60). The flow rate was
1.0  ml/min  and  eluent  was  monitored  at  245  nm;  the  selected  chromatographic
conditions  were found to  be effectively separate  telmisartan  (RT-  5.35 min)  and
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ramipril (RT-10.30 min). Linearity for telmisartan and ramipril were found in the
range of 16-24 µg/ml and 2-3 µg/ml, repectively. The proposed method can be used
forthe simultaneous estimation of these drugs in tablet formulation.
D.Isocratic  Rp-Hplc  Method  Development  And  Validation  For  The
Simultaneous Estmation Of Ramipril And Telmisartan In Tablet Dosage Form
Manju Latha et al .,(2012)
An RP-HPLC method has been developed for the simultaneous estimation of
ramipril  and  telmisartan  in  tablet  dosage  forms.  The  developed  method  was
validated  as  per  ICH  guidelines  and  specificity,  linearity  &  range,  accuracy,
precision and robustness was performed. Specificity was determined by comparing
the  results  obtained  by  running  the  placebo  solution  with  that  of  standard  and
method was found to be specific due to no interference between placebo peaks and
drugs peaks. Linearity range was found to be 4 to16 µg/ml and 32 to 128 µg/ml of
ramipril  and telmisartan  respectively.  The method was found to  be linear  in  the
range of4 to 16µg/ml and 32 to128 µg/ml for ramipril and telmisartan respectively.
In the linearity study, regression equation and coefficient of correlation for ramipril
and  telmisartan were found to  be (y = 924480x -  151831,  r  =0.9997)  and (y =
2901878.3558x + 3803877, r = 0.9996) respectively. This newly developed method
was successfully utilized for the simultaneous estimation of ramipril and telmisartan
in pharmaceutical tablet dosage forms.
Simultaneous Estimation of Ramipril and Telmisartan in Tablet Dosage
Form by Spectrophotometry, Popat B.Mohite et al ., (2010).
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Two simple, accurate, sensitive and specific methods are described for the
simultaneousdetermination  of  Ramipril  and  Telmisartan  in  binary  mixture.  The
method based on UVspectrophotometricdetermination of two drugs, Method A is by
using  multicomponant  method.  Itinvolves  absorbance  measurement  at  205.0
nm(λmax of Ramipril) and 291.0 nm (λmax ofTelmisartan) in 0.2M H2SO4;. Beer’s
law is obeyed in the concentration range of 5-40 µg mL-1 forRamipril and 2-20 µg
mL-1 for Telmisartan. Method B is graphical absorbance method which isbased on
measurement  of  absorbance  of  Ramipril  and  Telmisartan  at  222.0nm  (iso-
absorptivepoint of Ramipril and Telmisartan) and 291.0 nm (λmax of Telmisartan)
Both these methods havebeen successively applied to pharmaceutical formulation
and were validated according to ICHguidelines.
Simultaneous  Determination  of  Ramipril,  Hydrochlorothizide  and
Telmisartan by Spectrophotometry, Tapadiya.G.G et. al., (2009).
A simple, fast and precise multicomponent mode analysis method has been
developed for simultaneous determination of Ramipril (RMP), Hydrochlorothiazide
(HCT) and Telmisartan (TEL) in tablet formulation. The wavelengths selected for
these drugs were 218nm, 271nm and 296nm respectively using methanol as solvent.
The linearity for these drugs at all the selected wavelengths lies between 0.5-3.5
_gml-1for  RP,  1.25-8.75  _gml-1for  HCT  and  4-28  _gml-1for  TEL.
Theconcentrations of these drugs were evaluated in laboratory mixture and marketed
formulation. Accuracy was determined byrecovery studies from tablet dosages forms
and  ranges  from  99.09-99.52%.  Precision  of  method  was  find  out  as
repeatability,day to day and analyst to analyst variation and shows the values within
acceptable limit (R.S.D. _ 2 percent).
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 RP-HPLC  Method  for  Simultaneous  Estimation  of
Hydrochlorothiazide,Ramipril  and  Telmisartan  in  Tablet  Dosage  Form,
Anandkumar R. Tengli et al .,(2012).
A simple,  sensitive and specific  liquid chromatographic method with UV
detection  was  developed  for  the  simultaneous  estimation  of  hydrochlorothiazide,
ramipril and telmisartan in tablet dosage form and bisoprolol as internal standard.
Separation was achieved with an phenomenexluna 5µ  C18(2) 100R, 250X4.60 mm
5 micron size column, ambient temperature with a low pressure gradient mode with
mobile phase containing acetonitril, 0.5% of potassium dihydrogen phosphate buffer
pH 3.5 adjusted with orthophosphoric acid (50:50). The flow rate was 1 mL min-1
and eluent was monitored at 220 nm. The selected chromatographic conditions were
found  to  effectively  separate  hydrochlorothiazide,  ramipril  and  telmisartan  with
retention  time  of  3.1,  5.0  and  13.8  min  respectively.  The  linearity  range  of
hydrochlorothiazide, ramipril and telmisartan found in the range of 2-10 µgml-1, 5-
25 µgml-1 and 10-50 µgml-1 respectively. The proposed method was found to be
accurate,  precise,  reproducible  and  specific  and  it  can  also  be  used  for  routine
quality control analysis of these drugs in combination tablets.
Development and Validation of HPTLC Method for the Simultaneous
Estimation  of  Telmisartan  and  Ramipril  in  Combined  Dosage  Form,
Patel  .V .A et al .,(2010).
Developed and validated thin layer liquid chromatography (TLC) method for
the Simultaneous estimation of telmisartan and ramipril in a combined dosage form.
Procedure  does  not  require  prior  separation  of  components  from  the  sample.
Telmisartan  and  Ramipril  were  determined  by  High  Performance  Thin  Layer
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chromatography method (HPTLC) in tablet dosage form. The method was carried
out  in  TLC Precoated  silica  gel  on aluminum plate  60  F 254,  (10 cm ×10 cm,
prewashed by methanol and activated at 60° C for 5 min prior to chromatography).
The solvent system was Acetone: Benzene: Ethyl acetate: Glacial acetic acid in the
proportion of 5:3:2:0.03, (v/v/v/v) with Rf Value for telmisartan and ramipril was
0.673  and  0.353  respectively.  The  linearity  regression  analysis  for  calibration
showed 0.996 and 0.998 for telmisartan and ramipril with respect to peak area and
height  in  the  concentration  range  of  100-  1800  ng/spot  and  300-1800  ng/spot
respectively.  The  method  developed  can  be  used  for  routine  analysis  of  drugs
content in tablet dosage form
Simultaneous  estimation  of  telmisartan  and  ramipril  in  combined
dosage form by using HPTLC,  Sunil Singh et al., (2012).
In  this  paper  describes  developed  and  validated  thin  layer   liquid
chromatography (TLC) method for the  simultaneous estimation of telmisartan and
ramipril in a combined dosage form. Telmisartan and Ramipril were determined by
High Performance Thin Layer chromatography method (HPTLC) in tablet dosage
form. The method was carried out in TLC Precoated silica gel on aluminum plate 60
F 254, (10 cm ×10 cm, prewashed by methanol and activated at 60° C for 5 min
prior to chromatography). The solvent system was Acetone: Benzene: Ethyl acetate:
Glacial  acetic  acid  in  the  proportion  of  6:4:1:0.05,  (v/v/v/v)  with  Rf  Value  for
telmisartan and ramipril was 0.673 and 0.353 respectively. The linearity regression
analysis for calibration showed 0.999 and 0.998 for telmisartan and ramipril with
respect to peak area and height in the concentration range of 150- 1700 ng/spot and
Dept. of pharmaceutical Analysis                 51                   JKKMMRF College of Pharmacy
Chapter 2 Literature Review
300-1900  ng/spot  respectively.  The  method  developed  can  be  used  for  routine
analysis of drugs content in tablet dosage form.
simultaneous  determination  of  Ramipril  (RMP),  Hydrochlorothiazide
(HCT) and Telmisartan (TEL) in tablet formulation, Bankey.S et. al., (2011).
A simple, fast and precise multicomponent mode analysis method has been
developed for simultaneous determination of Ramipril (RMP), Hydrochlorothiazide
(HCT) and Telmisartan (TEL) in tablet formulation. The wavelengths selected for
these drugs were 218nm, 271nm and 296nm respectively using methanol as solvent.
The linearity for these drugs at all the selected wavelengths lies between 0.5-3.5
gml-1  for  RP,  1.25-8.75  gml-1  for  HCT  and  4-28  gml  -1  for  TEL.  The
concentrations of these drugs were evaluated in laboratory mixture and marketed
formulation.  Accuracy  was  determined  by  recovery  studies  from  tablet  dosages
forms  and  ranges  from  99.09-99.52%.  Precision  of  method  was  find  out  as
repeatability, day to day and analyst to analyst variation and shows the values within
acceptable limit (R.S.D. 2 percent).
stability-indicating  HPTLC  method  has  been  developed  for  the
quantitative simultaneous estimation of Telmisartan and Ramipril in combined
pharmaceutical dosage form and validation. Sivasubrahmanian, et al.,(2010),
A simple, selective, rapid, precise and stability-indicating HPTLC method 
has been developed for the quantitative simultaneous estimation of Telmisartan and 
Rampril in combined pharmaceutical dosage form and validation was done.  The 
proposed HPTLC method involves the use of HPTLC plates (Merck) precoated with
silica gel 60F254 on aluminium sheets and a mobile phase comprising of toluene: 
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acetonitrile: formic acid: water (5:5:0.3:1) Densiometric analysis of both the drugs 
was carried out in the absorbance mode at 212 nm.  This method has been 
successfully applied for estimation of Telmisartan and Ramipril in combined tablets 
formation.  Both the drugs were  subjected to acid‐alkali hydrolysis, oxidation and 
photolytic degradation and both of them were found to be susceptible to acid‐alkali 
hydrolysis, oxidation and photolytic degradation. Linearity of Telmisartan was 
found to be within the range of 500‐2500 ng/spot and for Ramipril the range was 
found to be 250‐1250 ng/spot, with significant high values of correlation coefficient 
for both the drugs. The method was validated for the precision, robustness and 
recovery. As method could effectively separate the drug from its degradation 
products, it can be employed as a stability indicating one. 
Isocratic  rp-hplc-uv  method  development  and  validation  forthe
simultaneous  estmation  of  ramipril  and  telmisartan  in  tablet  dosage  form,
Yogesh  et al .,(2009),
 An RP-HPLC method has been developed for the simultaneous estimation of
ramipril and telmisartan in tablet dosage forms, using UV-detector. The developed
method  was  validated  as  per  ICH  guidelines  and  specificity,  linearity&  range,
accuracy, precision and robustness was performed. Specificity was determined by
comparing the results obtained by running the placebo solution with that of standard
and method was found to be specific due to no interference between placebo peaks
and drugs peaks. Linearity range was found to be 4 to 16 µg/mland 32 to 128 µg/ml
of ramipril and telmisartan respectively. The method was found to be linear in the
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range of 4 to 16 µg/ml and 32 to 128 µg/ml for ramipril and telmisartan respectively.
In the linearity study, regression equation and coefficient of correlation for ramipril
and telmisartan were found to be (y = 924480x - 151831, r  = 0.9997) and (y =
2901878.3558x + 3803877, r = 0.9996) respectively. This newly developed method
was successfully utilized for the simultaneous estimation of ramipril and telmisartan
in pharmaceutical tablet dosage.
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DRUG PROFILE
Drug Name                  :                 Ramipril 
Molecular structure               :
IUPACNAME : (2S, 3aS, 6aS) - 1 - [(2S) - 2 - {[(2S) - 1 - ethoxy - 1 - oxo -
4 - phenylbutan - 2 - yl]amino} propanoyl] - octahydrocyclopenta [b] pyrrole - 2
- carboxylic acid 
Molecular formula : C23H32N2O5 
Molecular weight : 416.511 g/mol 
Category : Anti-hypertensive
Description : A white powder
Solubility : It is practically insoluble in water and freely 
soluble In methanol
Melting point : 109ºc
Purity : 99.90%
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Mechanism of action:  ACE inhibitors, as the name suggests, inhibit the
actions of angiotensin converting enzyme (ACE), thereby lowering the production
of angiotensin II and also decreasing the breakdown of bradykinin. The decrease in
angiotensin II results in relaxation of arteriole smooth muscle leading to a decrease
in total  peripheral  resistance,  reducing  blood  pressure  as  the  blood  is  pumped
through larger diameter vessels. Its effect on  bradykinin is responsible for the dry
cough side effect. Ramipril, a prodrug, is converted to the active metabolite ramipril
at  by liver esterase enzymes Ramipril  is  mostly excreted by the kidneys.  The half-
life of ramiprilat is variable (3–16 hours), and is prolonged by heart and liver failure,
as well as kidney failure.
Dosage: Doses in the ranges of 1.25, 2.5, 5.0 and 10 mg are available.
Pharmacokinetic data:
Absorption: oral
Distribution: Protein binding 56% -73% (ramipril)
Bioavailability:  28%
Metabolism: Hepatic
Half Life:  2 to 4 hours
Route of elimination: Renal (60%) and fecal (40%)
Therapeutic Uses: Indications for its use include:
 Hypertension;
Dept. of pharmaceutical Analysis                 56                   JKKMMRF College of Pharmacy
Chapter 3                                                                                                                Drug 
profile
 Congestive heart failure,
 Following heart attack in patients with clinical evidence of heart failure;
 Susceptible  patients  over  55  years:  prevention  of  heart  attack, stroke,
cardiovascular death or need of revascularization procedures.
 Diabetic nephropathy with microalbuminuria
 Adverse  effects:   low blood  sugar (in  patients  taking  medication  for
diabetes), causing sweating or shakiness
 dry cough
 dizziness and light-headedness due to low blood pressure
 tiredness and fatigue, especially in the early stages
 mouth dryness in the early stages
 nausea, vomiting, diarrhea (persistent in rare cases)
 fainting
 change in amount of urine
 signs of infection (e.g., fever, chills, persistent sore throat)
 yellowing of eyes or skin, dark urine
 stomach or abdominal pain
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 neutropenia (low white blood cells)
 impotence (erectile dysfunction) 
Serious allergic reactions to this drug are unlikely,  but  immediate medical
attention  must  be  sought  if  they occur.  Symptoms of  a  serious  allergic  reaction
include,  but  are not  limited  to  a rash or  swelling of  the  face,  mouth,  tongue,  or
throat.
In extreme cases, ramipril may lead to potentially fatal liver problems.
Contraindicated Renovascular disease, severe renal impairment (especially in
patients  with one kidney or  with bilateral renal  artery stenosis),  volume-depleted
patients, history of angioedema while on an ACE inhibitor, pregnancy, hypotension
Drug  interactions:  esomeprazole,  ramipril  alcohol/food  Interactions,  warfarin,
rosuvastatin,  Drospirenone,  Lithium,  Potassium,  Spironolactone,  Tizanidine,
Tobramycin, Treprostinil Triamterene
Storage: Keep this medication in the blister pack it came in, tightly closed, and out
of reach of children. Store it at room temperature and away from excess heat and
moisture (not in the bathroom). Throw away any medication that is outdated or no
longer  needed.  Talk  to  your  pharmacist  about  the  proper  disposal  of  your
medication.
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                                                           DRUG PROFILE
Drug Name                                         :   Telmisartan 
Molecular structure                          :
                                      
IUPAC NAME :  4'  -  [(1,4'  –  dimethyl  -  2'  -  propyl  [2,  6'  –  bi  -  1H
-benzimidazol] - 1' - yl) methyl] - [1, 1' - biphenyl] - 2 - carboxylic acid
Molecular formula : C33H30N4O2
Molecular weight : 514.63 g/mol
Category : Anti-hypertensive
Description : A white to slightly yellowish solid
Solubility:   It  is  practically  insoluble  in  water  and  in  the  pH range  of  3  to  9,
sparingly soluble in strong acid (except insoluble in hydrochloric acid), and soluble
in strong base
Melting point:  261-263ºc
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Purity: 99.80%
Mechanism of action:  Telmisartan is an angiotensin II receptor blocker that shows
high affinity for the angiotensin I receptor type II (AT1), with a binding affinity 3000
times greater for AT1 than AT2. It has the longest half-life of any ARB (24 hours) and
the largest volume of distribution
In addition to blocking the RAs, telmisartan acts as a selective modulator
of peroxisome proliferator-activated receptor gamma (PPAR-γ), a central regulator
of insulin and glucose  metabolism. It  is  believed that  telmisartan’s  dual  mode of
action may provide protective benefits against the vascular and renal damage caused
by diabetes and cardiovascular disease (CVD).
 Dosage: 20-80 mg
Pharmacokinetic data:
Absorption: oral
Distribution: Protein binding   ≥99.5%
Bioavailability: 42–100%
Metabolism: Minimal hepatic
Half Life: 24 hours
Route of elimination: Faecal 97%
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Therapeutic  Uses:  Telmisartan  is  indicated  in  the  treatment  of essential
hypertension.
Adverse effects:  Side effects are similar to other angiotensin II receptor antagonists
and  include tachycardia and bradycardia (fast  or  slow heartbeat), hypotension (low
blood pressure), edema (swelling of  arms,  legs,  lips,  tongue,  or  throat,  the  latter
leading to breathing problems), and allergic reactions.
Contraindicated:   Telmisartan  is  contraindicated  during pregnancy.  Like  other
drugs  affecting  the renin-angiotensin  system (RAS),  telmisartan  can  cause birth
defects,  stillbirths,  and neonatal  deaths.  It  should  not  be  taken  by breastfeeding
 women since it is not known whether the drug passes into the breast milk.
Drug interactions:  digoxin, amiloride, ketoprofen
Storage: Keep this medication in the blister pack it came in, tightly closed, and out
of reach of children. Store it at room temperature and away from excess heat and
moisture (not in the bathroom). Throw away any medication that is outdated or no
longer  needed.  Talk  to  your  pharmacist  about  the  proper  disposal  of  your
medication.
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AIM AND PLAN OF WORK 
From  the  literature  survey  conducted,  it  was  found  that  there  are  few
analytical methods reported for Ramipril and Telmisartan by reverse phase HPLC
method alone or in combination with other drugs. Presently the new formulation of
Ramipril  and  Telmisartan   is  available  in  market.  There  are  only  few  methods
reported  for  the  determination  of  Ramipril  and  Telmisartan  in  combined
pharmaceutical dosage form. So it was felt that there is a need to develop a sensitive
analytical method for the simultaneous estimation of Ramipril and Telmisartan in
Tablet dosage form available in market.
 AIM:
To develop a sensitive, simple, rapid and accurate analytical method for the
simultaneous  estimation  of  Ramipril  and  Telmisartan in  formulations  and
validation of developed method by using  RP-HPLC technique.
OBJECTIVE:
1. The scope of developing and validating method is to ensure a suitable strategy
for a particular analyte which is more specific, accurate and precise. Here the
main  focus  is  drawn  to  achieve  improvement  in  conditions  and  standard
operating procedures to be followed. 
2.  To develop a method that is rapid, sensitive and at the same time cost effective.
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PLAN OF WORK:
The plan of proposed work includes the following steps:
a) Method development by RP-HPLC
 Selection of suitable wave length.
 Selection of chromatographic technique.
 Method development trails
 Optimization of chromatographic condition.
b) Quantitative Estimation of Ramipril and Telmisartan by the developed method.
c) Validation  of  developed  method  using  following  parameters  as  per  the  ICH
guidelines.
 System suitability 
 Linearity 
 Precision
 Accuracy
 Robustness
 Limit of detection and Limit of quantification
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MATERIALS AND METHOD DEVELOPMENT
MATERIALS AND INSTRUMENTS
Table-6
Data Handling System: Empower-2 Software
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Instruments Name of the company
HPLC Waters 2695 (isocratic system)
UV-VIS  Spectrophotometer Lab India UV 3000+
Analytical Balance Shimadzu electronic balance (0.1mg-220g)
Ultra Sonicator Bandelin sonorex
Vacuum pump Gelman science vacuum pump 
pH meter Elico
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REAGENTS AND CHEMICALS
Name of the Chemical Name of the company
Methanol ,HPLC grade, Merck Merck
Acetonitrile ,HPLC grade, Merck Merck
Water (HPLC grade) Merck
Potassium dihydrogen Ortho phosphate (HPLC grade) Merck
Working standards of Ramipril and Telmesartan Hetero Labs
Table-7
Drug samples 
Ramipril  and Telmisartan pure drugs  were obtained as  gift  samples  from
Sipra labs, Hyderabad. 
Reference standards 
        1. Ramipril - % purity – 99.9
        2 .Telmisartan - % purity – 99.8
Formulation used 
          TAZLOC-R TM  tablets (Hetero Labs Ltd) containing 40mg of Telmisartan
and 5 mg of Ramipril was procured from local market.
5.1 RP-HPLC Technique for the estimation of Ramipril and Telmisartan 
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The high performance liquid chromatography technique is broadly divided in
to  two categories  namely  normal  phase  and  reverse  phase.  When the  stationary
phase used for chromatography is more polar than the mobile phase the technique in
called as normal phase chromatography and when the stationary phase used is non-
polar compared to the solvent used for mobile phase preparation the technique is
called as reverse phase chromatography. The sample elution order in normal phase
is  least  polar  first  whereas  it  is  most  polar  first  in  reverse  phase.  The effect  of
increasing solvent polarity in normal phase reduces elution time whereas in reverse
phase it increases elution time. HPLC has been most useful and versatile among all
chromatographic techniques because of its wider applicability to different classes of
compounds  and  the  sensitivity  levels  provided.  There  has  been  a  considerable
amount  of  improvement  in  the  hardware  used  since  its  innovation.  Major
improvement in the field has been due to change over to column with a 3-5µ particle
size instead of 30µ column used in the earlier days. HPLC has found application in
various sector of pharmaceutical industry. Various types of pharmaceutical analysis
such  as  drug assay and  dissolution testing  of  formulation  and  biological  studies
require a very versatile, sensitive and reliable technique like HPLC. Whereas ultra
high resolution is the requirement for assay and stability studies, faster analysis with
moderate resolution is the requirement for biostudies in a faster analysis with the
higher  resolution and  better  sensitivity.  Various  research  teams have  studied the
effect of using different stationary phases, solvent strength effect and temperature
has  also  been  studied.  Original  developments  carried  out  using  normal  phase
chromatography on silica columns have been gradually replaced by reverse phase
and separation due to the versatility associated with the latter technique.
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The  most  column  stationary  phase  has  been  used  is  the  octadecylsilane
chemically bonded to the silica using different bonding and end capping techniques,
almost 50% of the total  reverse phase separations carried out today are  reported
using this stationary phase. Although these stationary phases have a great potential
in  terms  of  the  three  most  sought  after  parameters  in  chromatography  namely
separation, selectivity and speed, they have been hardly exploited for the purpose.
Some  research  team  have  worked  and  reported  various  developed  method  for
separation of different  mixture, by controlling different  parameters which help in
achieving these goals.  A practical  approach for method development and method
validation are considered greatly with respect to separation selectivity and speed.
Selection of column:
Initially different C8 and C18 columns were tried for selected composition of
mobile phase and quality of peaks were observed for the drugs. Finally the column
was fixed upon the satisfactory results of various system suitability parameters such
as  column efficiency,  retention  time,  tailing  factor,  peak,  and  asymmetry  of  the
peaks.
Selection of Wavelength:
The  wavelength  for  the  analysis  was  selected  from the  UV spectrum of
ramipril  and  telmisartan  by scanning in  the range  of  200-400nm. From this,  the
wavelength of  230nm was selected for the RP-HPLC method as these drugs has
shown good absorbances.Fig.1
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Fig.1. Overlain absorption spectra of Ramipril and Telmisartan in Methanol
Selection of mobile phase:
To  develop  a  precise  and  robust  HPLC  method  for  simultaneous
determination of Ramipril and telmisartan, its standard solution were injected in the
HPLC system. After literature survey and solubility data different composition of
mobile phase of different flow rates were employed in order to determine the best
condition for effective separation of both drugs.
Selection of chromatographic technique: 
The choice of the method is based on the nature of the sample.  Ramipril and
Telmisartan  are  freely  soluble  in  solvents  like  methanol  and  acetonitrile  and
practically insoluble in water. So the reverse phase chromatographic technique was
selected for the present study.
In RP-HPLC technique, generally C18 and C8 columns are used as stationary
phase. For the present study C8 column is used as stationary phase.
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Method development trails:
Preparation of Phosphate buffer:
Weighed 2.68 grams of KH2PO4 into a 1000ml beaker, dissolved and diluted
to 1000ml with HPLC water. Adjusted the pH to 5 with Orthophosphoric acid
Preparation of mobile phase
Mix a mixture of above buffer 700 ml (70%) and Acetonitrile 300 ml (30%)
and degas in ultrasonic water bath for 5 minutes. Filter through 0.45 µ  filter under
vacuum filtration.
 Method Development Trails
Different  chromatographic  conditions  were  tried  to  optimize  the  method,
which include the following:
Trial 1:
Mobile phase  :  20 mM phosphate buffer :Methanol: Acetonitrile (40:5:55%v/v)
Column           :  Zorbax SB C8, 150 X 4.6mm, particle size 3.5µ    
Flow rate        :  0.8 ml/min 
Temparature   : a) column tempature:300c
                          b)sample temperature:250c
Detection           :  230 nm 
Retention time   : 2.568 min 
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Result: Fronting of Ramipril and no resolution for Telmisartan was observed.  
Trial 2:
Mobile phase       : 20 mM phosphate buffer: Methanol: Acetonitrile (40:5:55%v/v)
Column               :  Zorbax SB C8, 150 X 4.6mm, particle size 3.5µ    
Flow rate             :  1.0 ml/min
Temparature        : a) column tempature:300c
                               b)sample temperature:250c
Detection             :  230 nm
Retention time     :  3.148 and 4.324 min
Result: Fronting of Ramipril peak and assymetric peak of Telmisartan was observed
Trial 3:
Mobile phase       : 20 mM phosphate buffer: Methanol: Acetonitrile (45:25:30%v/v)
Column               :  Zorbax SB C8, 150 X 4.6mm, particle size 3.5µ    
Flow rate            : 1.0 ml/min
Temparature       : a) column tempature:300c
                             b)sample temperature:250c
Detection              :  230 nm
Retention time      : 3.215 and 5.073 min
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Result:  Fronting  of  Ramipril  peak  and  asymmetric  peak  of  Telmisartan  was
observed.
Trial 4:
Mobile phase           : 20 mM phosphate buffer: Acetonitrile (55:45%v/v)
Column                   : Zorbax SB C8, 150 X 4.6mm, particle size 3.5µ    
Flow rate                : 1.0 ml/min
Temparature          : a) column tempature:300c
                                b)sample temperature:250c
Detection              :  230 nm
Retention time      :  2.057 and 2.253 min
Result: Peak broadening of Ramipril and Tailing of Telmisartan was observed.
Trial 5:
Mobile phase           : 20 mM phosphate buffer: Acetonitrile (70:30%v/v)
Column                    :  Zorbax SB C8, 150 X 4.6mm, particle size 3.5µ    
Flow rate                 : 1.0 ml/min
Temparature            : a) column tempature:300c 
                                 b)sample temperature:250c
Detection              : 230 nm
Retention time      : 2.285 and 4.288
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Result:  Both  Ramipril  and  Telmisartan  peaks  show good  symmetry  and  with  a
resolution of 2.5.
5.2.2 OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
Stationary phase : Zorbax SB C8, 150 X 4.6mm, particle size 3.5µ    
Flow rate : 1.0ml/min
Temparature                     : a) column tempature:300c
                                            b)sample temperature:250c
Selected wave length : 230 nm.
Mobile phase ratio : 20 mM phosphate buffer: Acetonitrile (70:30%v/v)
Diluent : mobile phase
    Injection volume : 10 µl
    Run time : 6min.
Preparation of standard solution 
Weight  accurately  about  10  mg  of  ramipril  80  mg  of  telmisartan  and
transferred in to a clean 100 ml volumetric flask dissolved in few ml of methanol
and make up to the volume with methanol.  Sonicate for 10 minutes and filtered
through membrane filter and marked as standard stock solution.
Preparation of sample solution 
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Weigh  and  powder  20  tablets,  weight  accurately  a  quantity  of  powder
equivalent to 10 mg of ramipril and 80 mg of telmisartan and transfered it into a
clean 100 ml standard flask.  Add few ml of methanol and dissolved, make up the
volume with methanol.  The solution is sonicated for 10 minutes and filtered through
membrane filter, and marked as sample stock solution. 
Validation of the Method
Validation Report
Validation studies were carried out as per the protocol. The data is compiled
and discussed in the subsequent part of this report under the relevant parameters.
System suitability parameters and System precision
The  standard  solution,  prepared  using  ramipril  and  telmisartan  working
standard as per test method was injected six times into HPLC system.
The system suitability parameters and % relative standard deviation (RSD)
for peak areas for six replicate injections was found to be with in limits.
System suitability parameters Ramipril Telmisartan
Tailing factor 1.427 1.831
Resolution 9.248
No. of theoretical plates 5882 3045
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Table: 8 System Suitability
Table: 9 System Precision
Linearity of Detector Response
The linearity of an analytical  procedure is  its  ability to obtain test  results
which are directly proportional to the concentration (amount) of the analyte in the
sample.
Different Approaches for linearity determination are; 
The first approach is to weigh different amounts of authentic sample directly
to  prepare  linearity  solutions  of  different  concentrations.Another  approach  is  to
prepare a stock solution of high concentration, then perform serial dilution from the
stock  solution  to  obtain  solutions  of  lower  concentrations  for  linearity
determination.Linearity was assessed by performing single measurement at several
analyte concentrations. Varying quantities of the mixed standard stock solutions was
diluted with the mobile phase to give concentration of 20 – 60 µg/ml of ramipril and
160 – 480 µg/ml of telmisartan.
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Fig.2.1. Ramipril
                                                 Fig.2.2. Telmisartan
S.No Ramipril Telmisartan
Concentration (µg / ml) Peak Area Concentration (µg / ml) Peak Area
1
20
501718
160 3224684
2 30 751814 240 4833730
3 40 1005711 320 6445802
4 50 1250286 400 8052727
5 60 1499770 480 9664372
Slop 25003 Slop 20132
Intercept 1439.1 Intercept 1754.9
Correlation coefficient 0.9999 Correlation coefficient 1.0000
Table: 10 Linearity Test
Acceptance Criteria
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The correlation coefficient should be not less than 0.999. 
Precision of test method
The  precision  of  an  analytical  procedure  expresses  the  closeness  of
agreement between a series of measurements from multiple sampling of the same
homogenous sample under prescribed conditions. Precision may be considered at
three levels.
• Repeatability
• Intermediate precision
• Reproducibility
Repeatability
Repeatability expresses  the precision under  the same operating conditions
over a short internal   of time.
Repeatability  of  a  method  can  be  determined  by  multiple  replicate
preparations of the same sample.  This is  can be done either  by multiple sample
preparation  in  the  same  experiment  or  by  preparing  3  replicates  at  3  different
concentrations.
Intermediate precision
Intermediate  precision  expresses  within  laboratories  variations,  different
days, different analysts, different equipments etc.
Reproducibility
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Reproducibility expresses the precision between laboratories.
This  is  optional  validation  parameter  that  requires  demonstration  of
laboratory-to-laboratory  variation  only  if  multiple  laboratories  use  the  same
procedure.
Repeatability
The precision of test  method was evaluated by assaying six samples of a
single batch of ramipril and telmisartan tablet formulations.
Sample no. Area forRamipril
Area for
Telmisartan Ramipril assay
Telmisartan
assay
1 1000248 6441837 9.98 99 79.97 99.96
2 1006401 6439339 10.04 100.48 79.94 99.92
3 1002225 6468698 10.0 100.06 80.30 100.38
4 1004116 6442674 10.02 100.20 79.98 99.97
5 1003631 6416405 10.02 100.17 79.65 99.57
6 1003324 6441791 10.01 100.17 79.97 99.96
Average 1004843 6447719 10.01 100.15 79.97 99.96
Std.
Deviation 0.827 0.712 0.655 0.2042 0.404 0.2574
%RSD 0.801 0.709 0.66 0.2038 0.4 0.2575
Table: 11 Method Precision
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Drug
Amount (mg/tablet)
% Drug
content SD % RSD٭
Label Estimated
Ramipril 10 10.01 100.15 0.2042 0.2038
Telmisartan 80 79.97 99.96 0.2574 0.2575
Table: 12 Estimation of formulation.
Acceptance criteria
The % RSD (Relative Standard Deviation) of assay result should be not more
than 2.0%.
Accuracy
The  accuracy  of  an  analytical  procedure  expresses  the  closeness  of
agreement between the value which is accepted either as a conventional true value
or an accepted reference value and the value found.
Accuracy is often determined by recovery studies in which the analytes are
spiked into a solution containing the matrix.  The matrix  should be found not to
interfere with the assay of the compound of interest.
A recovery study of  ramipril  and  telmisartan  was conducted by mixing a
known quantity of standard drug with the preanalyzed sample formulation and the
contents were reanalysed by the proposed methods.
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The preanalyzed formulation solution (10 µg / ml equivalent to ramipril) was
spiked with different concentration of the standard solution of ramipril 5, 10, 15 µg /
ml. The amount recovered was calculated.   
The preanalyzed formulation solution (80 µg / ml equivalent to telmisartan)
was spiked with different concentration of the standard solution of telmisartan 40,
80, 120 µg / ml. The amount recovered was calculated.
Samples solutions were placed in triplicate for each spike level and assayed as per
the test method. The % recovery was found to be within the limits.
Drug
Amount
added in (µg /
ml)
Amount
Found in (µg /
ml)
Percentage
recovery SD
%
RSD
Ramipril
5 4.99 99.80 0.2314 0.2306
10 10.02 100.20 0.0545 0.0545
15 15.02 100.10 0.4894 0.4223
Telmisartan
40 40.04 100.10 0.5627 0.5349
80 80.09 100.11 0.4164 0.5382
120 120.13 100.10 0.4089 0.5347
Table: 13  ACCURACY
Acceptance Criteria
% Recovery should be within 97.0 to 103.0% of the added amount.
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ROUBUSTNESS
The robustness of  an analytical  procedure  is  a measure of its  capacity  to
remain  unaffected  by  small,  but  deliberate  variation  in  method  parameters  and
provides an indication of its reliability during normal usage.
As part of the Robustness, deliberate change in the Flow rate, Mobile Phase
composition, Temperature variation was made to evaluate the impact on the method.
SampleName Inj RT Area
Temperature1 Ramipril         1 2.273 1002292
Temperature2 Ramipril         1 2.282 996330
Flow rate 1 Ramipril         1 1.830 805697
Flow rate 2 Ramipril         1 3.030 1319197
                                                         Table-14
                                              Component summary table
                                                            RAMIPRIL
SampleName Inj RT Area
Temperature1 Telmisartan         1 4.231 6329892
Temperature2 Telmisartan         1 4.262 6282947
Flow rate 1 Telmisartan         1 5.604 8354170
Flow rate 2 Telmisartan         1 3.490 5051669
                                                           Table-15   
                                             Component summary table
                                                       TELMISARTAN
Temparature-1: 250c , Temparature-2:  350c
Flowrate-1:  0.8 ,Flowrate-2: 1.2
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Limit of Detection (L.O.D)
The LOD is the smallest concentration of the analyte that gives a measurable
response (signal to noise ratio of 3). The detection limit of an individual analytical
procedure is the lowest amount of analyte in a sample that can be detected but not
necessarily  quantified  as  an  exact  value.  Detection  limit  corresponds  to  the
concentration that will give a signal-to-noise ratio of 3:1.
The  lowest  amount  of  analyte  in  sample  that  can  be  detected,  but  not
necessary quantified was determined by comparison of measured signal with 2.727
µg/ml and 2.990 µg/ml of  ramipril and telmisartan  standard solutions respectively
with those of blank (Mobile phase).
                                                        
s.no Parameter Name Inj RT Area
1 LOD Ramipril 1 2.280 427694
2 LOD
Telmisartan
1 4.320 3141789
                                                                 TABLE-16
                                            Component Summary Table for LOD
                                                RAMIPRIL& TELMISARTAN
Limit of Quantitation (L.O.Q)
The LOQ is the smallest concentration of the analyte, which gives response
that can be accurately quantified (Signal to noise ratio of 10). The quantification
limit  of  an  individual  analytical  procedure  is  the lowest  amount  of  analyte  in  a
sample that can be determined quantitatively with suitable precision and accuracy.  
The Quantification  limit  is  the  concentration  of  related  substances  in  the
sample that will give a signal to noise ratio of 10:1.
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The lowest  amount of analyte  in the sample that  can be determined with
acceptable precision and accuracy was determined by the comparison of measured
signal  with  9.091  µg/ml  and  9.968  µg/ml  of  ramipril  and  telmisartan  standard
solution respectively with those of blank (mobile phase).
s.no Parameter Name Inj RT Area
1 LOQ Ramipril 1 2.279 540073
2 LOQ Telmisartan 1 4.310 3868301
                                                                 TABLE-17
                                            Component Summary Table for LOQ
                                                RAMIPRIL& TELMISARTAN
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Fig: 3.1 Trail - 1
Fig: 3.2 Trail - 2
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Fig: 3.3 Trail – 3
Fig: 3.4 Trail - 4
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Fig: 3.1 Trail – 5
Fig: 4 Blank Mobile Phase
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Fig: 5 Chromatogram of Ramipril standard
Fig: 6 Chromatogram of Telmisartan standard
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SYSTEM SUITABILITY& SYSTEM PRECIESION
Fig: 7.1 Fig: 7.2
Fig: 7.3
Fig: 7.4
Fig: 7.5                   Fig: 7.6
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LINEARITY
Fig: 8.1  Linearity -1
Fig: 8.2  Linearity -2
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Fig: 8.3  Linearity -3
Fig: 8.4  Linearity - 4
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Fig: 8.5  Linearity -5
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Fig: 9.1- 9.6 METHOD PRECISION
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Fig: 10.7- 10.9  ACCURACY STUDIES
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Fig: 11.1 – 11.2 ROBUSTNES STUDIES
Fig: 11.3 – 11.4 ROBUSTNES STUDIES
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Fig: 11.3 – 11.4 ROBUSTNES STUDIES
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Fig: 12.1 LOD
Fig: 12.2 LOQ
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RESULTS AND DISCUSSION
Selected  drug  combination  ramipril  and  telmisartan  is  available  in  fixed
dosage combination mainly in tablet dosage forms. Many methods are available for
estimation of the same as single components or in combination with other drugs.
Hence an involvement was made in this project to device a simple, accurate,
less expensive, and sensitive RP-HPLC method for the simultaneous estimation of
ramipril and telmisartan was developed and validated. 
A  simple  reverse  phase  liquid  chromatographic  method  has  been
developedand subsequently validated for simultaneous determination of ramipril and
telmisartan in combined tablet dosage form. The separation was carried out by using
a mobile phase consisting of 20 mM phosphate buffer of pH 5.0 : Acetonitrile in the
ratio of 70:30%v/v. The column used was Zorbax SB C8, 150 X 4.6mm, particle size
3.5µ with flow rate of 1.0ml/min using PDA detection at 230 nm.
The  chromatogram  of  ramipril  and  telmisartan  reference standard  are
presented  in  Figure  5  &  6  respectively.For  quantitative  estimation  230  nm was
selected as suitable wavelength.  The individual peaks of ramipril and  telmisartan
was identified by knowing the retention time 2.275 and 4.261 minutes respectively.
Linearity was evaluated by visual inspection of the plot of peak area as a
function of analyte concentration for ramipril and  telmisartan. The data regarding
linearity for both the drugs were given in  Table 10 and  corresponding calibration
graphs were shown in Figure2.1&2.2. The linearity of the method was determined at
concentration levels ranging from 20-60 µg/ml for  ramipril and 160-480 µg/ml for
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telmisartan. The correlation co-efficient of ramipril was found to be 0.9999 and the
correlation co-efficient of telmisartan was found to be 1.0000, these are within limit.
System suitability parameters such as resolution, tailing factor and number of
theoretical plates are presented in Table 8
System precision was carried out, the % RSD for peak area of ramipril and
telmisartan  for six replicated injections was not more than 2.0% and the data was
presented in Table 9.
Estimation  of  ramipril  and telmisartan  tablet  dosage  forms  by  RP-
HPLCmethod was carried out using optimized chromatographic  conditions.   The
standard and sample solutions were prepared. The chromatograms were recorded.
The peak area ratio of standard and sample solutions was calculated. The results of a
analysis shows that the amount of drugs was in good agreement with the label claim
of the formulation. The quantitative estimation was carried out on tablet by taking
the same concentration  as  for  standard  solution.  The data  regarding  quantitative
estimation  is  depicted  in Table  12. The  tablet  shows  percentage  purity  values
ranging from 100.15 for ramipril and 99.96 for telmisartan respectively.
The acceptance criteria of method precision were found to be % RSD NMT
2.0% and  the  method shows  precision  of  0.20423 for  ramipril and  0.25752 for
telmisartan. Table.11
The accuracy of the method was determined by recovery experiments. The
recovery study was carried out and the percentage recovery range found to be within
the limit,  99.8-100.20  percentage  for  ramipril and 100.10-100.11 percentages  for
telmisartan. Table.13
Dept. of pharmaceutical Analysis                 99                JKKMMRF College of Pharmacy
Chapter 7 Results and Discussion
The Limit  of Detection (LOD) and Limit  of Quantification (LOQ) of the
developed method were determined by injecting progressively low concentrations of
the  standard  solutions  using  the  developed  RP-HPLC  method.  The  LOD  is  the
smallest concentration of  the analyte that  gives a measurable response (signal  to
noise ratio of 3). The Detection Limit (LOD) was found to be 2.727 µg/ml and 2.990
µg/ml of ramipril and telmisartan respectively.
The LOQ is the smallest concentration of the analyte, which gives response
that can be accurately quantified (signal to noise ratio of 10). The quantitation limit
(LOQ) was found to be  9.091 µg/ml and 9.968 µg/ml of ramipril and telmisartan
respectively.
The  method  was  validated  as  per  ICH  guidelines  in  terms  of  linearity,
accuracy, specificity, precision, repeatability of measurement of peak area as well as
repeatability of sample application and the results are shown.  Since this developed
method can be used for routine analysis of two components in formulation.
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Validation parameters Ramipril Telmisartan
Linearity range (µg/ml) 20-60 µg/ml 160-480 µg/ml
Correlation co-efficient 0.9999 0.9999
Retention time (min) 2.275 min 4.261 min
LOD  (µg/ml) 2.727 2.990
LOQ  (µg/ml) 9.091 9.968
Accuracy 100.03 100.1
System precision 
(% RSD)
0.79 0.68
No.  of  theoretical  plates
9.248
Resolution factor 
5882
3045Tailing factor 1.427 1.831
Slope 25003 20132
Intercept 1439.1 1754.9
Method precision (% RSD 0.2038 0.2575
VALIDATION PARAMETERS HPLC METHOD
                                                            Table -14
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S. No Parameters
Observation
Limit Pass/fail
Ramipril Telmisartan
1 Linearity  range(µg/ml) 20-60 µg/ml 160-480 µg/ml No limit passed
2 Correlation  co-
efficient 0.9999 0.9999
NLT-
0.999 passed
3
System precision
(% RSD)
0.79 0.68 NMT 2 passed
4 Accuracy 50% level 99.80 100.10 97-103 passed
5 Accuracy 100% level 100.20 100.11 97-103 passed
6 Accuracy 150% level 100.10 100.10 97-103 passed
7 Method precision (%RSD) 0.2038 0.2575 NMT 2 passed
                                                                   Table-15
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                                               CONCLUSION
From the  reported  literature,  there  were  few methods  established  for  the
determination of Ramipril  and Telmisartan in individual and in combination with
other drug. 
It  was  concluded  that  there  were  only  few  methods  reported  for  the
simultaneous estimation of the above selected multi component dosage form, which
promote to pursue the present work. The scope and objective of the present work is
to develop and validate a new simple RP-HPLC method for simultaneous estimation
of Ramipril and Telmisartan in combined dosage form. 
In  simultaneous RP-HPLC method development,  Waters 2695 Separations
Module with PDA  Detector   and column used is C8 SB ZORBAX (150 X 4.6mm)
column with3.5-micron  particle  size.  Injection  volume of  10  µL is  injected  and
eluted with the mobile phase selected after optimization was  Phosphate buffer and
Acetonitrile in the ratio of 70:30 was found to be ideal. The flow rate was found to
be optimized at  1.0  mL/min.  Detection was carried out  at  230 nm. This  system
produced symmetric peak shape, good resolution and reasonable retention times of
Ramipril and Telmisartan were found to be 2.275 and 4.261 minutes respectively. 
The Ramipril and Telmisartan showed linearity in the range of 20-60 µg/mL
and 160-480 µg/mL respectively.
Precision of the developed method was studied under system precision and
method precision. The %RSD values for precision was found to be within   the
acceptable  limit,  which  revealed  that  the  developed  method  was  precise.  The
developed method was found to be robust. The %RSD value for percentage recovery
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of Ramipril  and Telmisartan was found to be within the acceptance criteria.  The
results indicate satisfactory accuracy of method for simultaneous estimation of the
Ramipril and Telmisartan.   
From the above experimental data and results, the developed HPLC method
is having the following advantages: 
 The standard and sample preparation requires less time. 
 No tedious extraction procedure was involved in the analysis of formulation. 
 Run time required for recording chromatograms were less than 10 minutes. 
 Suitable for the analysis of raw materials, applicable to dissolution studies
and can be used for the content uniformity studies. 
Hence,  the  chromatographic  method  developed  for  the  Ramipril  and
Telmisartan said to be rapid, simple, specific, sensitive, precise, accurate and reliable
that can be effectively applied for routine analysis in research institutions, quality
control  department in industries,  approved testing laboratories,  bio-pharmaceutics
and bio-equivalence studies and in clinical pharmacokinetic studies.
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